Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Antimicrobial Resistance, and Poultry Vaccination

Introduction

Avian pathogenic Escherichia coli (APEC) constitutes a major pathotype of extraintestinal pathogenic E. coli (ExPEC) responsible for significant economic losses in poultry production worldwide. APEC is the primary etiological agent of colibacillosis, a disease complex that encompasses respiratory tract infection, septicemia, polyserositis, yolk sac infection, and cellulitis in chickens and turkeys. The pathogenesis of colibacillosis involves a multistep process beginning with inhalation or ingestion of the bacterium, followed by colonization of the respiratory epithelium, evasion of host immune defenses, and systemic dissemination. The severity of disease is determined by the arsenal of virulence factors encoded within the APEC genome, many of which are carried on mobile genetic elements such as plasmids, pathogenicity islands, and prophages [1, 14]. The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) APEC strains has further complicated control efforts, limiting therapeutic options in both conventional and organic production systems [7, 8]. In response, vaccination has become a cornerstone of sustainable colibacillosis management, with autogenous, bacterin, and recombinant subunit vaccines increasingly deployed in commercial broiler and layer flocks. This review provides an exhaustive examination of APEC serotypes, virulence mechanisms, antimicrobial resistance trends, and current vaccination approaches, with emphasis on molecular diagnostic strategies and computational vaccine design.

Serotypes and Virulence Factors

APEC strains exhibit considerable serotypic diversity, with the O-antigen (somatic) and H-antigen (flagellar) typing systems serving as the primary classification framework. The most frequently reported serotypes associated with colibacillosis include O1, O2, O78, O8, O15, and O18, among others [11, 14]. Serotype O78 has been particularly implicated in severe systemic infections, and strains belonging to this serogroup often harbor multiple virulence-associated genes (VAGs). The virulence repertoire of APEC can be categorized into several functional classes: adhesins, iron acquisition systems (siderophores), protectins (capsule and lipopolysaccharide), toxins, and type III and type VI secretion system effectors.

Key virulence factors include the following:

• fim genes encoding type 1 fimbriae, which mediate attachment to mannose-containing receptors on epithelial cells.
• pap (pyelonephritis-associated pili) operon involved in adherence to respiratory and urogenital epithelia.
• iuc/iut genes encoding aerobactin siderophore and its receptor, critical for iron scavenging in iron-limited host environments.
• iss (increased serum survival) gene associated with resistance to complement-mediated killing.
• tsh (temperature-sensitive hemagglutinin) contributing to adherence and hemagglutination.
• vat (vacuolating autotransporter toxin) promoting vacuolation and cell death.
• hcp genes encoding components of the type VI secretion system (T6SS), such as Hcp2a, which has been shown to induce incomplete autophagy in chicken HD11 macrophage-like cells, thereby subverting host innate immunity [13].
• ecnAB toxin-antitoxin system that modulates capsular sialic acid biosynthesis, influencing virulence and persistence [12].

A summary of representative virulence-associated genes and their functions is presented in Table 1.

Table 1. Major virulence-associated genes of Avian Pathogenic Escherichia coli.

The presence and combination of these VAGs define the pathogenic potential of a given APEC isolate. Molecular typing methods, including multiplex PCR and whole-genome sequencing, are routinely employed to identify virulent strains and to differentiate APEC from avian fecal commensal E. coli. Genomic characterization of an XDR APEC strain revealed multiple plasmid-borne resistance determinants alongside a dense complement of VAGs, illustrating the convergence of resistance and virulence within clonal lineages [14].

Pathogenesis of Colibacillosis

Colibacillosis typically manifests in one of several forms depending on the age of the host, route of infection, and immune status. In broiler chickens, the most common presentation is respiratory colibacillosis, which often follows primary viral infections such as Infectious Bursal Disease Virus or Avian Coronavirus Variants (Infectious Bronchitis Virus) that compromise respiratory mucosal integrity and ciliary clearance. After inhalation, APEC adheres to the tracheal and air sac epithelium via fimbrial adhesins, resists complement-mediated opsonization through capsule and Iss protein, and acquires iron via siderophores. Bacterial multiplication leads to airsacculitis, pericarditis, perihepatitis, and peritonitis. Systemic dissemination results in septicemia and death.

The polyserositis observed in colibacillosis is characterized by fibrinous exudates on serosal surfaces, which commonly yield pure cultures of APEC upon bacteriological sampling. Histopathological findings include heterophilic infiltration, fibrin deposition, and necrosis of underlying parenchyma. The inflammatory response is exacerbated by bacterial toxins, including lipopolysaccharide (LPS) and Vat, which trigger proinflammatory cytokine release and pyroptosis. The T6SS effector Hcp2a exacerbates cellular injury by disrupting autophagic flux, as demonstrated in the chicken macrophage cell line HD11 [13]. Additionally, the ecnAB toxin-antitoxin system contributes to the regulation of capsular polysaccharide biosynthesis, thereby modulating both immune evasion and persistence within host tissues [12].

Antimicrobial Resistance

The widespread use of antimicrobial agents in poultry production, both for therapeutic and prophylactic purposes, has driven the emergence and dissemination of resistant APEC clones. Resistance profiles include single-agent resistance, multidrug resistance (MDR, defined as resistance to three or more antimicrobial classes), and extensively drug-resistant (XDR) phenotypes. A comprehensive meta-analysis of E. coli from food-producing animals in Nigeria revealed high prevalence of extended-spectrum beta-lactamase (ESBL)-producing isolates, with CTX-M and TEM enzymes being predominant [8]. Similarly, surveillance of livestock populations in subtropical environments reported elevated resistance to tetracyclines, sulfonamides, and fluoroquinolones, with co-resistance patterns mediated by integrons and plasmids [7]. Pet birds have also been identified as potential reservoirs of antimicrobial-resistant bacteria in digestive and respiratory infections, underscoring the zoonotic and ecological dimensions of APEC resistance [6].

Resistance mechanisms in APEC include:

• Enzymatic inactivation (e.g., beta-lactamases, aminoglycoside-modifying enzymes).
• Target site modification (e.g., gyrA mutations for fluoroquinolones, altered penicillin-binding proteins).
• Efflux pump overexpression (e.g., AcrAB-TolC, Tet efflux systems).
• Reduced outer membrane permeability (e.g., porin loss).

The convergence of resistance and virulence genes on mobile elements poses a particular challenge. Whole-genome sequencing of an XDR APEC strain of serotype O78 identified a large conjugative plasmid carrying blaCTX-M-15, aac(3)-II, tet(A), and sul2, in addition to multiple virulence genes including iss, iucA, and tsh [14]. Such co-localization facilitates the co-selection and dissemination of virulence and resistance determinants under antimicrobial pressure.

Phage-based interventions are under investigation as alternatives to antibiotics. One study demonstrated that a temperature-dependent coliphage induces distinct temporal bacterial morphological dynamics during infection, suggesting potential for phage therapy against APEC [5]. Additionally, the targeting of bacterial signaling pathways, such as c-di-GMP via monoclonal antibodies directed against diguanylate cyclase DgcE, has been shown to potentiate gentamicin activity against APEC, offering a novel approach to enhance antibiotic efficacy [3].

Vaccination Strategies

Vaccination is a critical component of integrated colibacillosis control, particularly in layer flocks where the disease manifests as chronic salpingitis and peritonitis, and in broiler breeders where vertical transmission via infected yolk sacs results in early chick mortality. Three broad categories of vaccines are used in poultry: autogenous (inactivated) bacterins, commercial whole-cell bacterins, and recombinant or subunit vaccines.

Autogenous vaccines are prepared from field isolates cultured from affected flocks and are typically inactivated with formalin or beta-propiolactone and adjuvanted with mineral oil or aluminum hydroxide. These vaccines offer serotype-specific protection and can be tailored to the circulating APEC strains within a farm or region. However, their efficacy depends on the antigenic match between the vaccine strain and the challenge strain, and cross-protection against heterologous serotypes may be limited.

Recombinant subunit vaccines targeting conserved virulence factors or outer membrane proteins are under active development. A meta-analysis of epitope-based and peptide-based vaccines against APEC, combined with machine learning insights, identified peptide sequences from fimbrial proteins, porins, and iron receptors as promising immunogens capable of eliciting both humoral and cell-mediated responses [4]. Another study demonstrated that a multi-epitope hemagglutinin (HA) vaccine conferred cross-protective immunity against H5N8 and H9N2 influenza viruses, illustrating the potential for combination vaccines that target both viral and bacterial pathogens associated with colibacillosis [2].

Adjuvant and immunomodulatory strategies are also being explored. Polysaccharides derived from Atractylodes macrocephala Koidz. have been shown to protect against APEC-induced intestinal barrier dysfunction via suppression of PI3K/Akt-mediated claudin-2 upregulation, suggesting their utility as feed additives to enhance mucosal immunity and gut integrity [9]. Sihuang Zhili Granules, a Chinese herbal formulation, exhibited protective effects against APEC O78 challenge through modulation of gut homeostasis, as demonstrated by integrative analysis of 16S rRNA sequencing and network pharmacology [11].

The computational design of vaccines using reverse vaccinology and structural prediction has accelerated the identification of conserved epitopes. Advances in AlphaFold-based modeling and molecular docking allow rational design of multi-epitope constructs that can be expressed in E. coli or viral vectors. A decision tree for selection of vaccination strategy is presented in Figure 1.

flowchart TD
    A[Flock history of colibacillosis], > B{Single serotype?}
    B, Yes, > C[Autogenous bacterin preparation]
    B, No, > D{Multiple serotypes or MDR?}
    D, Yes, > E[Recombinant subunit vaccine targeting conserved antigens]
    D, No, > F[Commercial bacterin + biosecurity]
    C, > G[Molecular characterization of isolate (serotyping, VAGs, resistome)]
    G, > H[Inactivated vaccine production with adjuvant]
    H, > I[Field efficacy monitoring]
    E, > J[Machine learning epitope prediction [4]]
    J, > K[Peptide synthesis or recombinant expression]
    K, > L[Challenge trials in target flock]
    L, > I
    F, > I
    I, > M[Adjust vaccine formulation or rotation]

Figure 1. Decision tree for selection of APEC vaccination strategy based on serotype prevalence, resistance profile, and computational design.

Diagnostic Approaches

Accurate diagnosis and characterization of APEC are essential for both therapeutic decision-making and vaccine formulation. Bacteriological culture followed by serotyping with O-antisera remains the classical reference method. However, molecular detection using multiplex PCR targeting VAGs (e.g., iss, iucA, tsh, papC) provides faster and more definitive identification of pathogenic potential. Whole-genome sequencing (WGS) using short-read or long-read platforms enables detailed resistome and virulome analysis and allows phylogenetic comparison across flocks and regions [14]. Genomic surveillance data can be integrated with computational modeling to predict outbreak risk and guide vaccine strain selection.

Advanced diagnostic tools such as MALDI-TOF mass spectrometry and matrix-assisted laser desorption/ionization time-of-flight are increasingly used for rapid species identification. Additionally, enzyme-linked immunosorbent assays (ELISAs) for detection of APEC-specific antibodies or antigens are valuable for flock-level serosurveillance, though cross-reactivity with other E. coli pathotypes can limit specificity. Biosensor-based platforms and microfluidic lab-on-a-chip systems represent emerging technologies for point-of-care detection of APEC in poultry house environments.

Conclusion

Avian pathogenic Escherichia coli remains a persistent threat to global poultry health and productivity, driven by its extensive virulence gene arsenal and accelerating antimicrobial resistance. Understanding the molecular mechanisms of pathogenesis, including toxin-antitoxin systems and secretion system effectors, informs the development of targeted countermeasures. Multidrug resistance, including ESBL production and XDR phenotypes, necessitates a shift from reliance on antibiotics to integrated management strategies encompassing biosecurity, autogenous and recombinant vaccination, and alternative therapeutics such as phage therapy and immunomodulators. Computational approaches, including machine learning for epitope prediction and genomic epidemiology, are poised to play an increasingly central role in the rational design of cross-protective vaccines and the surveillance of emergent resistant clones. Continued research into host-pathogen interactions, vaccine adjuvant systems, and real-time diagnostic technologies will be essential for sustainable colibacillosis control in both conventional and alternative poultry production systems.

References

1. Lisnanti EF, Lokapirnasari WP, Arif MAA, et al. Comparative effects of Myrmecodia sp. extract and infusion on organ function biomarkers, lipid metabolism, and meat lipid profile in avian pathogenic Escherichia coli-infected broiler chickens: Implications for sustainable poultry production within a One Health framework. Vet World. URL: https://pubmed.ncbi.nlm.nih.gov/42245456/

2. Zahra B, Behzad H, Morteza T, et al. Multi-epitope HA Vaccine Confers Cross-protective Immunity to H5N8 and H9N2. Arch Razi Inst. URL: https://pubmed.ncbi.nlm.nih.gov/42226989/

3. Fangfang L, Lianhua N, Haiyang W, et al. An IgM monoclonal antibody targeting diguanylate cyclase DgcE potentiates gentamicin activity against avian pathogenic Escherichia coli through modulation of c-di-GMP signaling. BMC Vet Res. URL: https://pubmed.ncbi.nlm.nih.gov/42226053/

4. Waseem M, Kamran Z, Ali A. Advancing poultry health: A meta-analysis of epitope-based and peptide-based vaccines against Avian Pathogenic E. coli with machine learning insights. PLoS One. URL: https://pubmed.ncbi.nlm.nih.gov/42201941/

5. Pattano J, Prasasti FFTA, Buddhasiri S, et al. Temperature-dependent coliphage induces distinct temporal bacterial morphological dynamics during infection. Microbiol Spectr. URL: https://pubmed.ncbi.nlm.nih.gov/42200651/

6. Crăciun S, Turcu MC, Novac CŞ, et al. Pet Birds as Potential Reservoirs of Antimicrobial-Resistant Bacteria in Digestive and Respiratory Infections. Antibiotics (Basel). URL: https://pubmed.ncbi.nlm.nih.gov/42192709/

7. Kanwal B, Asif E, Kalhoro NH, et al. Prevalence of Antimicrobial-Resistant Bacterial Pathogens Among Livestock in Subtropical Environments. Antibiotics (Basel). URL: https://pubmed.ncbi.nlm.nih.gov/42192683/

8. Yakubu Y, Gaddafi MS, Hassan UL, et al. Systematic Review and Meta-Analysis of Extended-Spectrum Beta-Lactamase-Producing (ESBL) Escherichia coli in Food-Producing Animals and Animal Products in Nigeria. Antibiotics (Basel). URL: https://pubmed.ncbi.nlm.nih.gov/42192654/

9. Chen S, Qu X, Wu J. Polysaccharide from Atractylodes macrocephala Koidz. protects against avian pathogenic Escherichia coli-induced intestinal barrier Dysfunction via Suppressing PI3K/Akt-Mediated Claudin-2 upregulation. Poult Sci. URL: https://pubmed.ncbi.nlm.nih.gov/42184735/

10. Hao J, Li L, Yang Y, et al. Screening of strategies for enhancing and preserving antibacterial efficacy: optimizing inactivation and desiccation of black soldier fly larvae against avian enteric pathogens. Poult Sci. URL: https://pubmed.ncbi.nlm.nih.gov/42176583/

11. Guo Z, Wang X, Cai D, et al. Integrative analysis of 16S rRNA sequencing and network pharmacology suggests protective effects of Sihuang Zhili Granules against APEC O78 challenge through gut homeostasis-related changes. Front Vet Sci. URL: https://pubmed.ncbi.nlm.nih.gov/42164768/

12. Jing Y, Shen X, Yin D, et al. The ecnAB toxin-antitoxin system modulates avian pathogenic Escherichia coli virulence through regulating the capsular sialic acid biosynthesis pathway. Vet Microbiol. URL: https://pubmed.ncbi.nlm.nih.gov/42160786/

13. Tian Y, Zhang Y, Lu L, et al. Avian pathogenic Escherichia coli virulence protein Hcp2a induces incomplete autophagy in chicken HD11 cells. Poult Sci. URL: https://pubmed.ncbi.nlm.nih.gov/42155397/

14. Ni W, Chen L, Chen H, et al. Genomic and Pathogenic Characterization of an Extensively Drug-Resistant Avian Pathogenic Escherichia coli Strain. Transbound Emerg Dis. URL: https://pubmed.ncbi.nlm.nih.gov/42147456/

15. Li X, Xue W, Xiao S, et al. Converting One In Vitro Selected DNA Molecule Into Two Bacteria-Responsive DNAzymes by Regulation of Reaction Conditions. Angew Chem Int Ed Engl. URL: https://pubmed.ncbi.nlm.nih.gov/42139110/